InvestorsHub Logo
Followers 40
Posts 6165
Boards Moderated 1
Alias Born 04/10/2012

Re: IB_ post# 384318

Thursday, 08/10/2023 4:16:33 PM

Thursday, August 10, 2023 4:16:33 PM

Post# of 401388
I anticipate the same type of stair-stepping revenues in the coming months and years, not unlike how we went from barely anything to $30-34M in a few years. I would expect a larger and quicker snowball from here vs starting at ground zero. We also have an opportunity to grow the existing Adderrall ER product by 1.5-2x or more by selling it ourselves. That’s before the Oxy generic and whatever the other “needle movers” are. Also doesn’t count any developments overseas.

Anyone’s guess as to how and when the stock responds to the above.

I’ve brought up in my CC Q’s that I think it’s time (past time) for a share buyback program, all salaries in cash and a more aggressive IR outreach. If we can afford to spend hundreds of millions on R&D over the years, we can afford to spend 500k-1M+ on a buyback, even one would change the general calculus/sentiment around here. My opinions only.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News